Human IgG antibody Laboratories manufactures the rv 111 cb cell biolabs reagents distributed by Genprice. The Rv 111 Cb Cell Biolabs reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Cell Biolabs. Other Rv products are available in stock. Specificity: Rv Category: 111 Group: Cb Cell
CB 300919 |
|||
| HY-14375 | MedChemExpress | 50mg | EUR 2116 |
CB-6644 |
|||
| HY-114429 | MedChemExpress | 1mg | EUR 796 |
CB-5083 |
|||
| HY-12861 | MedChemExpress | 10mM/1mL | EUR 113 |
CB-103 |
|||
| HY-135145 | MedChemExpress | 100mg | EUR 131 |
CB-7921220 |
|||
| HY-101862 | MedChemExpress | 10mM/1mL | EUR 126 |
CB-1158 |
|||
| HY-101979 | MedChemExpress | 25mg | EUR 1179 |
CB 300919 |
|||
| A3285-10 | ApexBio | 10 mg | EUR 864 |
|
Description: CB 300919 is a potential therapy for ovarian cancer. Preclinical data showed that this quinazoline-based compound CB 300919 has a continuous exposure (96 h) growth inhibition IC50 value of 2 nM in human CH1 ovarian tumor xenograft. |
|||
CB 300919 |
|||
| A3285-5 | ApexBio | 5 mg | EUR 505 |
|
Description: CB 300919 is a potential therapy for ovarian cancer. Preclinical data showed that this quinazoline-based compound CB 300919 has a continuous exposure (96 h) growth inhibition IC50 value of 2 nM in human CH1 ovarian tumor xenograft. |
|||
CB 300919 |
|||
| A3285-50 | ApexBio | 50 mg | EUR 2764 |
|
Description: CB 300919 is a potential therapy for ovarian cancer. Preclinical data showed that this quinazoline-based compound CB 300919 has a continuous exposure (96 h) growth inhibition IC50 value of 2 nM in human CH1 ovarian tumor xenograft. |
|||
CB-839 |
|||
| B4799-10 | ApexBio | 10 mg | EUR 258 |
CB-839 |
|||
| B4799-100 | ApexBio | 100 mg | EUR 862 |
CB-839 |
|||
| B4799-5 | ApexBio | 5 mg | EUR 171 |
CB-839 |
|||
| B4799-50 | ApexBio | 50 mg | EUR 595 |
CB-5083 |
|||
| B6032-10 | ApexBio | 10 mg | EUR 270 |
|
Description: IC50: 15.4 nMCB-5083 is an orally bioavailable inhibitor of p97. P97 is an AAA-ATPase involved in multiple cellular functions such as organelle membrane homotypic fusion and sorting of endosomal cargo. |
|||
CB-5083 |
|||
| B6032-100 | ApexBio | 100 mg | EUR 920 |
|
Description: IC50: 15.4 nMCB-5083 is an orally bioavailable inhibitor of p97. P97 is an AAA-ATPase involved in multiple cellular functions such as organelle membrane homotypic fusion and sorting of endosomal cargo. |
|||
CB-5083 |
|||
| B6032-5 | ApexBio | 5 mg | EUR 189 |
|
Description: IC50: 15.4 nMCB-5083 is an orally bioavailable inhibitor of p97. P97 is an AAA-ATPase involved in multiple cellular functions such as organelle membrane homotypic fusion and sorting of endosomal cargo. |
|||
CB-5083 |
|||
| B6032-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 235 |
|
Description: IC50: 15.4 nMCB-5083 is an orally bioavailable inhibitor of p97. P97 is an AAA-ATPase involved in multiple cellular functions such as organelle membrane homotypic fusion and sorting of endosomal cargo. |
|||